iBio Inc.

NASDAQ: IBIO · Real-Time Price · USD
0.74
0.06 (9.14%)
At close: Aug 15, 2025, 3:59 PM
0.75
1.47%
After-hours: Aug 15, 2025, 07:56 PM EDT

iBio Income Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Revenue
375K 375K 175K 225K 50K 50K 50K n/a 61K 2M 2.17M 2.38M 2.81M 1.64M 2.17M 2.37M 3M 2.33M 1.94M
Cost of Revenue
-744K -412K -25K 225K 1M 950K 862K 612K 596K 362K 176K 216K 388K 833K 931K 998K 1.11M 703K 492K
Gross Profit
1.12M 787K 200K n/a -950K -900K -812K -612K -535K 1.64M 2M 2.17M 2.42M 802K 1.24M 1.37M 1.89M 1.63M 1.45M
Operating Income
-16.81M -15.56M -15.64M -16.63M -18.19M -20.73M -26.81M -29.34M -41.27M -47.29M -43.95M -45.28M -37.83M -32.85M -33.16M -31.11M -24.6M -21.46M -17.07M
Interest Income
581K 552K 482K 363K 190K 170K 169K 213K 230K 247K 241K 178K 111K 223K 215K 183K 186K 38K 15K
Pretax Income
-16.46M -14.23M -14.36M -15.44M -17.13M -20.77M -26.85M -29.31M -41.43M -47.54M -44.17M -41.82M -24.66M -19.93M -20.87M -23.21M -26.86M -23.87M -19.51M
Net Income
-20.99M -19.3M -23.15M -24.91M -23.16M -27.28M -52.63M -65.01M -76.03M -81.13M -59.49M -50.3M -33.13M -28.4M -24.61M -23.21M -26.86M -23.88M -19.51M
Selling & General & Admin
10.96M 10.71M 10.93M 11.67M 11.84M 12.64M 17.48M 19.02M 27.01M 28.8M 26.38M 25.47M 21.51M 21.51M 21.94M 23.34M 20.39M 18.24M 15.01M
Research & Development
6.23M 5.23M 4.88M 5.18M 6.4M 8.14M 9.38M 10.33M 14.31M 14.94M 14.02M 13.98M 10.74M 9.63M 10.21M 9.46M 6.72M 5.55M 4M
Other Expenses
n/a n/a n/a n/a n/a -98K -98K -98K -111K -61K -174K -214K -201K -152K -37K 3K 4K 3K 3K
Operating Expenses
17.19M 15.6M 15.48M 16.53M 17.91M 20.78M 26.86M 29.34M 41.32M 43.69M 40.24M 37.87M 30.67M 29.61M 30.74M 32.7M 27M 23.69M 18.91M
Interest Expense
228K 226K 203K 172K 129K 112K 109K 83K 291K 256K 225K 834K 1.26M 1.88M 2.49M 2.5M 2.46M 2.46M 2.46M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.19M 15.94M 15.81M 16.86M 18.24M 20.78M 26.86M 29.34M 41.34M 49.29M 50.52M 52.07M 45.05M 38.89M 35.33M 33.48M 27.6M 23.79M 19.01M
Income Tax Expense
n/a n/a 34K 34K 34K 69K 35K 35K 21.14M 21.31M 21.31M 21.92M 816K 608K 1.22M 615K 1.23M 1.23M 618K
Shares Outstanding (Basic)
9.86M 9.13M 8.63M 8.62M 3.71M 1.86M 1.2M 1.02M 765.37K 490K 884.2K 872.7K 800.68K 718.07K 741.37K 435.75K 862.16K 752.35K 324.88K
Shares Outstanding (Diluted)
9.86M 9.13M 8.63M 8.62M 3.71M 1.86M 1.2M 1.02M 1.1M 490K 884.2K 872.7K 871.9K 871.5K 871.5K 434.04K 862.16K 752.35K 324.88K
EPS (Basic)
-2.33 -2.69 -6.63 -10.96 -16 -26.22 -56.01 -71.72 -109.51 -112.89 -92.4 -92.5 -48.64 -54.19 -60.47 -51.46 -59.62 -49.57 -374.57
EPS (Diluted)
-2.33 -2.69 -6.63 -10.97 -16.01 -26.23 -56.02 -92.22 -130.01 -133.39 -112.86 -92.46 -48.6 -54.15 -60.47 -64.87 -73.03 -62.98 -387.98
EBITDA
-15.11M -12.84M -12.95M -14.09M -16.07M -19.78M -25.88M -28.12M -39.71M -39.5M -35.43M -32.8M -24.99M -25.69M -26.45M -28.37M -22.06M -19.11M -14.79M
EBIT
-16.23M -14.01M -14.15M -15.27M -17M -20.66M -26.74M -29.23M -41.14M -41.69M -38.38M -39.18M -21.62M -21.89M -22.17M -20.76M -24.41M -21.42M -17.05M
Depreciation & Amortization
1.12M 1.17M 1.21M 1.18M 1.21M 1.16M 1.14M 1.38M 1.43M 2.14M 2.63M 2.95M 3.22M 2.83M 2.64M 2.41M 2.35M 2.31M 2.27M